Commodore Capital’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,410,384
| Closed | -$19.4M | – | 35 |
|
|
2024
Q3 | $19.4M | Hold |
3,410,384
| – | – | 1.21% | 25 |
|
|
2024
Q2 | $15.8M | Hold |
3,410,384
| – | – | 1.08% | 25 |
|
|
2024
Q1 | $27.9M | Sell |
3,410,384
-389,616
| -10% | -$3.18M | 1.86% | 19 |
|
|
2023
Q4 | $21.5M | Buy |
+3,800,000
| New | +$21.5M | 1.88% | 20 |
|
|
2022
Q2 | – | Sell |
-481,094
| Closed | -$11.7M | – | 25 |
|
|
2022
Q1 | $11.7M | Hold |
481,094
| – | – | 2.61% | 15 |
|
|
2021
Q4 | $15.5M | Hold |
481,094
| – | – | 3.59% | 13 |
|
|
2021
Q3 | $21.5M | Hold |
481,094
| – | – | 5.67% | 5 |
|
|
2021
Q2 | $18.2M | Hold |
481,094
| – | – | 6.34% | 4 |
|
|
2021
Q1 | $17.8M | Hold |
481,094
| – | – | 7.09% | 2 |
|
|
2020
Q4 | $15.9M | Buy |
+481,094
| New | +$15.9M | 8.67% | 1 |
|